Regular exercise and cutting your calorie intake remains the best way to lose weight (Image: Getty) Semaglutide, the type 2 diabetes medication that's become a sensation in the celebrity weight loss scene, known widely as Ozempic and Wegovy, might soon be overshadowed. Fresh research indicates that a comparable drug that also boosts insulin has shown 'significant' weight loss benefits for those battling obesity. The surge in obesity and associated rise in type 2 diabetes cases have seen semaglutide and its counterparts herald a new era in managing these debilitating health issues.
Numerous patients have successfully reversed their diabetes linked to obesity, and many who have found diets ineffective are witnessing their waistlines diminish. Yet, as with any medical innovation, ongoing studies continue to shed light on the effectiveness of these treatments. Enter tirzepatide, another breakthrough diabetes drug, which similarly imitates a hormone called GLP-1 that your body releases in the gut upon eating, leading to an uptick in insulin production.
A large study published in JAMA Internal Medicine has found that this medication is "significantly" more potent in promoting weight loss than Ozempic. function loadOvpScript(){let el=document.createElement('script');el.
setAttribute('src','https://live.primis.tech/live/liveView.
php?s=114945&playerApiId=v114945');document.getElementById('ovp-primis').appendChild(el)}window.
top.addEventListener('primisPlayerInit',e=>{try{if(e.detail&&e.
